Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TARRYTOWN, N.Y., Aug. 1, 2013 /PRNewswire/ -- EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced operating and financial results for the three and six months ended June 30, 2013, and provided an update on the Company’s upcoming merger with Immune Pharmaceuticals, Ltd. (Immune).
Help employers find you! Check out all the jobs and post your resume.
